This week, the overall grades of three Health Care Provider stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Mednax Inc. (NYSE:MD) is on the decline this week, earning a D (“sell”) after getting a C (“hold”) last week. Mednax provides physician management services to hospital-based neonatal, maternal-fetal, pediatric cardiology, and pediatric intensive care specialties. Shares of MD have declined 2.9% over the past month, worse than the 1.2% increase the S&P 500 has seen over the same period. For a full analysis of MD stock, visit Portfolio Grader.
The rating of Tenet Healthcare (NYSE:THC) slips this week from a C to a D. Tenet Healthcare is an investor-owned health care services company that mainly operates general hospitals and related health care facilities, such as outpatient surgery centers, diagnostic imaging centers and a number of medical office buildings. The stock also gets an F in Margin Growth. The trailing PE Ratio for the stock is 42.3. The stock has declined 8.6% over the past thirty days. For more information, get Portfolio Grader’s complete analysis of THC stock.
China Cord Blood (NYSE:CO) earns a D this week, moving down from last week’s grade of C. China Cord Blood engages in the provision of umbilical cord blood storage and ancillary services in its cord blood banks. The stock also gets an F in Earnings Revisions. Since last month, shares of CO are down 6.7%. To get an in-depth look at CO, get Portfolio Grader’s complete analysis of CO stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.